News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program


7/17/2012 9:56:45 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital research organization (dCRO), today announced Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has awarded the company an Oncology Program. Immediate plans are commencing for two metastatic melanoma studies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES